Quarterly Results • Search Archive
Dr. Reddy's Laboratories Limited
Results, Financials & Updates
Follow Dr. Reddy's Laboratories Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Dr. Reddy's Laboratories Limited: latest results and financials
About the business in Nivata's latest coverage
Dr. Reddy's Laboratories Limited is a global pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of generic pharmaceuticals, active pharmaceutical ingredients (APIs), biosimilars, and proprietary formulations across multiple international markets. The company operates primarily through two major business segments: Global Generics, which covers finished dosage pharmaceutical products across various therapeutic areas, and Pharmaceutical Services and Active Ingredients (PSAI), which handles active ingredients and custom pharmaceutical development and manufacturing (CDMO) services.
Quarter history
Dr. Reddy's Laboratories Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹8,099.80 Cr · PAT ₹435.60 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.